{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:11:59Z","timestamp":1762459919292,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T00:00:00Z","timestamp":1596499200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ebiom.2020.102953","type":"journal-article","created":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T05:02:34Z","timestamp":1598245354000},"page":"102953","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Quantification, epitope mapping and genotype cross-reactivity of hepatitis B preS-specific antibodies in subjects vaccinated with different dosage regimens of BM32"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5825-2687","authenticated-orcid":false,"given":"Inna","family":"Tulaeva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolin","family":"Cornelius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Zieglmayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9","family":"Zieglmayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9","family":"Schmutz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Lemell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milena","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarete","family":"Focke-Tejkl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Karaulov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Henning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudolf","family":"Valenta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2020.102953_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-422X-10-239","article-title":"Medical virology of hepatitis B: how it began and where we are now","volume":"10","author":"Gerlich","year":"2013","journal-title":"Virol J"},{"key":"10.1016\/j.ebiom.2020.102953_bib0002","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S2468-1253(19)30119-0","article-title":"A global scientific strategy to cure hepatitis B","volume":"4","author":"Revill","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.ebiom.2020.102953_bib0003","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00430-014-0373-y","article-title":"Prophylactic vaccination against hepatitis B: achievements, challenges and perspectives","volume":"204","author":"Gerlich","year":"2015","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.ebiom.2020.102953_bib0004","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0092-8674(86)90663-X","article-title":"Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus","volume":"46","author":"Neurath","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2020.102953_bib0005","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/0264-410X(89)90235-1","article-title":"Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective","volume":"7","author":"Neurath","year":"1989","journal-title":"Vaccine"},{"key":"10.1016\/j.ebiom.2020.102953_bib0006","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1053\/j.gastro.2005.03.090","article-title":"Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes","volume":"129","author":"Glebe","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ebiom.2020.102953_bib0007","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1128\/JVI.79.3.1613-1622.2005","article-title":"Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein","volume":"79","author":"Gripon","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.ebiom.2020.102953_bib0008","first-page":"1","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"2012","author":"Yan","year":"2012","journal-title":"Elife"},{"key":"10.1016\/j.ebiom.2020.102953_bib0009","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s12072-016-9718-5","article-title":"Hepatitis B virus receptors and molecular drug targets","volume":"10","author":"Verrier","year":"2016","journal-title":"Hepatol Int"},{"key":"10.1016\/j.ebiom.2020.102953_bib0010","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/S0264-410X(00)00461-8","article-title":"Immunotherapy of chronic hepatitis B by anti HBV vaccine: from present to future","volume":"19","author":"Michel","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.ebiom.2020.102953_bib0011","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00430-014-0374-x","article-title":"Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1\/Pre-S2\/S Vaccine","volume":"204","author":"Shouval","year":"2015","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.ebiom.2020.102953_bib0012","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jaci.2015.12.1299","article-title":"Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: lessons from the past and novel mechanisms of action for the future","volume":"137","author":"Valenta","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ebiom.2020.102953_bib0013","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.imlet.2017.04.015","article-title":"Recombinant allergy vaccines based on allergen-derived B cell epitopes","volume":"189","author":"Valenta","year":"2017","journal-title":"Immunol Lett"},{"key":"10.1016\/j.ebiom.2020.102953_bib0014","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ebiom.2019.11.006","article-title":"Two years of treatment with the recombinant grass pollen allergy vaccine BM32 induces a continuously increasing allergen-specific IgG4 response","volume":"50","author":"Eckl-Dorna","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ebiom.2020.102953_bib0015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ebiom.2016.08.022","article-title":"Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy","volume":"11","author":"Zieglmayer","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ebiom.2020.102953_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2017.09.052","article-title":"Safety and efficacy of immunotherapy with the recombinant B-cell epitope\u2013based grass pollen vaccine BM32","volume":"142","author":"Niederberger","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ebiom.2020.102953_bib0017","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ebiom.2016.07.023","article-title":"Immunotherapy with the PreS-based grass pollen allergy vaccine BM32 induces antibody responses protecting against hepatitis B infection","volume":"11","author":"Cornelius","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ebiom.2020.102953_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2011.02.004","article-title":"A hypoallergenic cat vaccine based on Fel d 1\u2013derived peptides fused to hepatitis B PreS","volume":"127","author":"Niespodziana","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ebiom.2020.102953_bib0019","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1093\/emboj\/20.16.4443","article-title":"HBV infection of cell culture: evidence for multivalent and cooperative attachment","volume":"20","author":"Paran","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.ebiom.2020.102953_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0117204","article-title":"Comparison of the specificities of IgG, IgG-subclass, IgA and IgM reactivities in African and European HIV-infected individuals with an HIV-1 clade C proteome-based array","volume":"10","author":"Gallerano","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2020.102953_bib0021","doi-asserted-by":"crossref","first-page":"D566","DOI":"10.1093\/nar\/gks1022","article-title":"HBVdb: a knowledge database for Hepatitis B Virus","volume":"41","author":"Hayer","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ebiom.2020.102953_bib0022","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1093\/bioinformatics\/btu531","article-title":"AliView: a fast and lightweight alignment viewer and editor for large datasets","volume":"30","author":"Larsson","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ebiom.2020.102953_bib0023","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/hep.25852","article-title":"Tracing hepatitis B virus to the 16th century in a Korean mummy","volume":"56","author":"Kahila Bar-Gal","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.ebiom.2020.102953_bib0024","first-page":"1","article-title":"The paradox of HBV evolution as revealed from a 16thcentury mummy","volume":"14","author":"Patterson Ross","year":"2018","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ebiom.2020.102953_bib0025","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41586-018-0097-z","article-title":"Ancient hepatitis B viruses from the bronze age to the medieval period","volume":"557","author":"M\u00fchlemann","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2020.102953_bib0026","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1002\/1521-4141(200208)32:8<2156::AID-IMMU2156>3.0.CO;2-A","article-title":"Conversion of grass pollen allergen-specific human IgE into a protective IgG(1) antibody","volume":"32","author":"Flicker","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.ebiom.2020.102953_bib0027","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1365-2222.2010.03666.x","article-title":"Recombinant monoclonal human immunoglobulin E to investigate the allergenic activity of major grass pollen allergen Phl p 5","volume":"41","author":"Madritsch","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.ebiom.2020.102953_bib0028","doi-asserted-by":"crossref","first-page":"W147","DOI":"10.1093\/nar\/gkw419","article-title":"Heatmapper: web-enabled heat mapping for all","volume":"44","author":"Babicki","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ebiom.2020.102953_bib0029","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3390\/genes9100495","article-title":"The global hepatitis B virus genotype distribution approximated from available genotyping data","volume":"9","author":"Velkov","year":"2018","journal-title":"Genes"},{"key":"10.1016\/j.ebiom.2020.102953_bib0030","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.3390\/cells9061486","article-title":"Hepatitis B virus entry into cells","volume":"9","author":"Herrscher","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ebiom.2020.102953_bib0031","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0168-8278(01)00028-9","article-title":"Efficacy and limitations of a specific immunotherapy in chronic hepatitis B","volume":"34","author":"Pol","year":"2001","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.ebiom.2020.102953_bib0032","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41565-020-0648-y","article-title":"Dual-targeting nanoparticle vaccine elicits a therapeutic antibody response against chronic hepatitis B","volume":"15","author":"Wang","year":"2020","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.ebiom.2020.102953_bib0033","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.virol.2012.04.007","article-title":"Optimization of immune responses induced by therapeutic vaccination with cross-reactive antigens in a humanized hepatitis B surface antigen transgenic mouse model","volume":"430","author":"Bourgine","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.ebiom.2020.102953_bib0034","doi-asserted-by":"crossref","first-page":"e26738","DOI":"10.7554\/eLife.26738","article-title":"A potent human neutralizing antibody Fc-dependently reduces established HBV infections","volume":"6","author":"Li","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.ebiom.2020.102953_bib0035","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jhep.2016.04.013","article-title":"First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B","volume":"65","author":"Blank","year":"2016","journal-title":"J Hepatol"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420303297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420303297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:04:00Z","timestamp":1762455840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396420303297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":35,"alternative-id":["S2352396420303297"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.102953","relation":{},"ISSN":["2352-3964"],"issn-type":[{"type":"print","value":"2352-3964"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantification, epitope mapping and genotype cross-reactivity of hepatitis B preS-specific antibodies in subjects vaccinated with different dosage regimens of BM32","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.102953","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102953"}}